Tradestie Institutional Equity Comparison Engine

BBNX vs DCTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BBNX trades at N/M Forward P/E with -72.8% operating margin (+30.3% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, BBNX sits in CONSOLIDATION (54th %ile IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DCTH
BBNX N/M vs DCTH N/M Fwd P/E
Growth & Margin Winner DCTH
Op Margin -72.8% vs 5.2% ยท YoY +30.3% vs +70.7%
Momentum & Technical Winner DCTH
1Y -40.5% vs +128.6% ยท 52W Pos 28% vs 80%
Options & Structure Winner DCTH
CONSOLIDATION (54th %ile IV) vs BREAKOUT (43rd %ile IV)
BBNX NASDAQ
Beta Bionics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$15.60
-4.99% 1D
Market Cap $897.6M
1M Return -4.59%
1Y Return -40.55%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 51.0 Fund 59.0 Flow 57.0 Mom 50.0
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BBNX -40.55% DCTH +128.57% Spread: +169.12 pp (DCTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BBNX Revenue DCTH Revenue BBNX Op. Margin DCTH Op. Margin Margin Edge
FY2013 N/A $0M N/A -4179.6% DCTH
FY2014 N/A $0M N/A -1805.8% DCTH
FY2015 N/A $0M N/A -870.6% DCTH
FY2021 N/A $0M N/A -690.0% DCTH
FY2022 N/A $0M N/A -1245.1% DCTH
FY2023 $10M $0M -298.9% -1849.0% BBNX
FY2024 $70M $40M -69.5% -33.4% DCTH
FY2025 $100M $90M -71.5% 0.8% DCTH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BBNX (3) vs DCTH (6)
Institutional Metric BBNX DCTH Criterion Row Winner
Market Capitalization Scale $897.6M $743.8M Larger Scale BBNX
Trailing P/E Ratio Valuation N/M 133.6x Lower Multiple DCTH
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +30.3% +70.7% Higher Growth DCTH
Operating Margin (TTM) Profitability -72.8% 5.2% Higher Margin DCTH
Net Profit Margin Profitability -65.3% 6.0% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency -23.9% 5.4% Higher ROE DCTH
52-Week Range Position Momentum 28% ($9โ€“$33) 80% ($8โ€“$23) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 1.83ฮฒ ยท 108% Vol 1.63ฮฒ ยท 131% Vol Lower Realized Risk BBNX
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite BBNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BBNX vs DCTH Buy Guide
BBNX CONSOLIDATION
84d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 54th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BBNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BBNX nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.